ICMI 2022

Overview

ICMI is the only meeting that focuses exclusively on the interface between the immune system and the environment at mucosal surfaces for our global community. It is the perfect occasion for cross-fertilization between scientists, clinical researchers and industry professionals working on pathways of immunity and inflammation at mucosal surfaces.

Program Quick Links:

Helpful Links

International Program Committee

Co-Chairs
Jennifer Lund, PhD, Fred Hutchinson Cancer Research Center
Mark Travis, PhD, The University of Manchester
Steven F. Ziegler, PhD, Benaroya Research Institute

Program Committee
William Busse, MD, University of Wisconsin, Madison
Ellen Foxman, MD, PhD, Yale School of Medicine
Kenya Honda, MD, PhD, Keio University School of Medicine
Molly Ingersoll, PhD, Institut Pasteur
Douglas Kwon, MD, PhD, Harvard University
Clare Lloyd, PhD, Imperial College, London
Benjamin Marsland, PhD, Monash University
Laura Mackay, PhD, The University of Melbourne
Toshinori Nakayama, MD, PhD, Graduate School of Medicine, Chiba University
Fiona Powrie, FRS, Oxford University
Joshua Schiffer, MD, Fred Hutchinson Cancer Research Center
Jonathan Spergel, MD, PhD, University of Pennsylvania

ICMI 2022 Objectives

Increase understanding of systemic and mucosal immune responses to SARS-CoV-2 infection and vaccination
Highlight therapeutic approaches to infections and diseases that affect mucosal sites
Be able to compare and contrast mucosal immune responses in distinct mucosal tissue types
Increase knowledge of microbial interactions with the mucosal immune system

COVID-19 Safety Policy

The Society has established a COVID-19 policy for all attendees for the 2022 ICMI meeting in accordance with all restrictions and requirements for the Seattle area. All attendees will be required to abide by the policy, which is subject to updates as the situation changes leading up to the meeting.

Read the Policy

2022 Sponsors

Scientific Program - All times are in Pacific Daylight Time

Time
8:00	Principles of Mucosal Immunology Course *Separate Registration Required
8:00-8:45	Registration Open
8:45-9:00	Welcome
9:00- 9:45	Adaptive immune responses to the gut microbiota (IgA, CD4 T cells) Timothy W. Hand, PhD UPMC Children's Hospital of Pittsburgh, University of Pittsburgh
9:45- 10:30	Immune sensing by epithelial barriers in mucosa Isabella Rauch, PhD Oregon Health and Science University
10:30- 10:45	Break
10:45- 11:30	Innate lymphoid cells and intestinal inflammation Lauren Zenewicz, PhD The University of Oklahoma, College of Medicine
11:30- 12:15	Modulation of genital inflammation and disease susceptibility by vaginal microbiota Douglas S. Kwon, MD, PhD Harvard Medical School/Ragon Institute of MGH, MIT and Harvard
12:15-13:00	Lunch Break (provided in the room)
13:00- 13:45	Cellular heterogeneity in the immune system: Turning a bug into a feature with single-cell genomics Alex K. Shalek, PhD MIT and Broad Institute
13:45-14:30	Michael Silverman, MD, PhD University of Pennsylvania, Children’s Hospital of Philadelphia
14:30-15:00	Break
15:00-15:45	Innate defenses against respiratory viruses Ellen Foxman, MD, PhD Yale University School of Medicine
15:45-16:30	Career Development Andreas Bäumler, PhD UC Davis School of Medicine
17:30-18:00	ICMI 2022 Welcome
18:00-19:00	Opening Keynote Plenary Yasmine Belkaid, PhD National Institutes of Health (NIH) Opening plenary supported by the Helmsley Charitable Trust.
19:00-20:30	Welcome Reception

Time
9:00-10:30	Plenary Session *IL-1 Cytokines Family and Barrier Immunity* Neuronal regulation of Type 2 Immunity De’broski R. Herbert, PhD, University of Pennsylvania School of Veterinary Medicine Stromal-immune interactions regulating pulmonary barrier immunity Clare Lloyd, PhD, Imperial College London Regulation of IL-33 at Mucosal Surfaces Marsha Wills-Karp, PhD, Johns Hopkins Bloomberg School of Public Health
10:00-10:30	Break
11:00-12:30	Oral Abstract Sessions
12:30-14:00	Network & Lunch
14:00-15:00	Concurrent Sessions *Genital Tract Immunity* Metabolic adaptation controls HIV-1 persistence in macrophages in vivos Morgane Bomsel, PhD, Institut Cochin Cenre De Recherche Regulation of vaginal tissue immunity in the context of infections Jennifer Lund, PhD, Fred Hutchinson Cancer Research Center *Upper Airway Diseases and Mucosal Immunity* Dynamic innate immune states of the airway epithelium in defense against respiratory viruses Ellen Foxman, MD, PhD, Yale School of Medicine Mucosal inflammation and disease in human upper airway Robert P. Schleimer, PhD, Northwestern University Feinberg School of Medicine
15:00-15:30	Break
15:30-17:00	Oral Abstract Sessions
17:00-19:00	Poster Reception - sponsored by
19:30-21:30	SMI Young Investigator Member Reception Sponsored by Benaroya Research Institute Note: Invite only

Time
9:00-10:30	Plenary Session *COVID-19 Pathogenesis Vaccinology* TBA Ralph Baric, PhD, UNC Gillings School of Global Public Health Inflammatory and protective responses to SARS-CoV-2 in hospitalized patients Peter Openshaw, MD, Imperial College London Immune memory to SARS-CoV-2 Marion Pepper, PhD, University of Washington
10:00-10:30	Break
11:00-12:30	Oral Abstract Sessions Vaccination at mucosal surface session sponsored by Vaxart
12:30-14:00	Network & Lunch
14:00-15:00	Concurrent Sessions *Microbiota and Infection* Impact of the lung microbiome on the innate immune response to respiratory infections Amanda Jamieson, PhD, Brown University A role for innate and adaptive immunity to Malassezia yeast in Crohn’s Disease David Underhill, PhD, Cedars Sinai Medical Center *Therapeutic Advances* Epithelial Cytokine Inhibitors in the Treatment of Atopic Disorders Jonathan Corren, MD, UCLA Specialized metabolic niches in the gut for IgA plasma cells Stephanie Eisenbarth, MD, PhD, Northwestern University School of Medicine
15:00-15:30	Break
15:30-17:30	Oral Abstract Sessions
17:30-19:00	Poster Reception - sponsored by

Time
9:00-10:30	Plenary Session Immune-Nervous System Interactions at Mucosal Surfaces Neuroimmune interactions in Eosinophilic asthma Matthew Drake, MD, Oregon Health & Science University Scratching that itch: neuroimmune control of allergic immunity Caroline Sokol, MD, PhD, Massachusetts General Hospital/Harvard Medical School Neuroimmune interactions in health and disease Henrique Veiga-Fernandes, PhD, Fundação Champalimaud
10:00-10:30	Break
11:00-12:30	Oral Abstract Sessions
12:30–14:00	Network & Lunch
14:00-15:00	Concurrent Sessions *Epithelial Control of Mucosal Immunity* Leveraging single-cell genomics to understand COVID-19 Alex K. Shalek, PhD, Massachusetts Institute of Technology Small Intestinal Tuft Cells: sentinels and effectors of type 2 immunity Jakob von Moltke, PhD, Washington University *Underappreciated Mucosal Sites* Divergent regulatory networks driving the allergic inflammation and esophageal epithelial remodeling in Eosinophilic Esophagitis subtypes Simon P. Hogan, PhD, University of Michigan Disentangling human tumor immune alterations from non-malignant tissue inflammation Martin Prlic, PhD, Fred Hutchinson Cancer Research Center
15:00-15:30	Break
15:30-17:00	Oral Abstract Sessions SMI Mentorship Program Presentations TAM receptors play distinct roles in lung homeostasis and inflammation Alessandra Filardy, PhD Laboratório de Imunologia Celular The effects of obesity-associated dysbiotic gut microbiota on the intestinal and adipose tissue inflammation Devesha Kulkarni, PhD, Washington University School of Medicine Long-term consequences of early life immune-microbial interactions Ziad Al Nabhani, PhD, Bern University Hospital Bi-directional signaling between the intestinal epithelium and type- 3 Innate Lymphoid Cells (ILC3) regulates their phenotype and function Joana F. Neves, PhD, King’s College London Milk-derived osteopontin supports the development of the intestinal immune system and gut microbiota Danyvid Olivares-Villagómez, PhD, Vanderbilt University Medical Center
17:00-19:00	Poster Reception - sponsored by

Time
9:00-10:30	President’s Rising Stars Abstract Plenary Chair: Michael McGuckin, PhD, University of Melbourne Single-cell RNA sequencing unveils intestinal eosinophil development and specialization Alessandra Gurtner, PhD Student, University of Zurich Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity Irina Leonardi, PhD, Weill Cornell Medical College Diet at birth conditions successful development of type 2 immunity Akila Rekima, PhD, Telethon Kids Institute / University of Western Australia Antibiotic-induced Malassezia spp. expansion in infants elicits intestinal immune dysregulation and increases airway inflammation in mice Erik van Tilburg Bernardes, PhD, Candidate, University of Calgary Regulatory T cell coordination of the mucosal NK cell response during viral infection Sarah Vick, PhD, Fred Hutchinson Cancer Research Center Presentation of Mucosal Immunology Journal Poster Awards
10:30-11:00	Break
11:00-12:30	Plenary Session Immune-Microbe Interactions in Homeostasis and Disease The intratumoral microbiota impact spatial and cellular heterogeneity within human oral and colorectal cancers Susan Bullman, PhD, Fred Hutchinson Cancer Research Center Roles for the Gut Microbiota in Health and Disease Wendy Garrett, MD, PhD, Harvard T.H. Chan School of Public Health Effects of Intestinal Microbes and Metabolites on Shaping Innate Immunity and Regulating Homeostasis Kathy McCoy, PhD, University of Calgary
12:30-13:00	Closing Address